FOXM1 and cancer: The presence of FOXM1 Apt as a therapeutic aptamer and Dox as a chemotherapeutic drug together in the design of the delivery platform increases the efficiency of cancer therapy and decreases toxicity for nontarget cells compared to free drugs by decreasing the required amount of Dox.